Pomalidomide Enhanced Antitumor Effect of Gemcitabine and Nab-Paclitaxel for Pancreatic Cancer Cells

被引：0
|
作者：
Saito, Nobuhiro [1 ]
Shirai, Yoshihiro [1 ]
Sugano, Hiroshi [1 ]
Horiuchi, Takashi [1 ]
Iwase, Ryota [1 ]
Haruki, Koichiro [1 ]
Shiba, Hiroaki [1 ]
Uwagawa, Tadashi [1 ]
Ohashi, Toya [1 ]
Yanaga, Katsuhiko [1 ]
机构：
[1] Jikei Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2016年 / 223卷 / 04期
关键词：
D O I：
10.1016/j.jamcollsurg.2016.08.365
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E142 / E142
页数：1
相关论文
共 50 条
  • [1] Effect of Preoperative Nab-paclitaxel and Gemcitabine on Pancreatic Cancer Stroma
    Ishido, K.
    Kimura, N.
    Wakiya, T.
    Nagase, H.
    Odagiri, T.
    Mitsuhashi, Y.
    Goto, S.
    Yoshizawa, T.
    Kijima, H.
    Hakamada, K.
    [J]. PANCREAS, 2019, 48 (10) : 1451 - 1451
  • [2] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
  • [4] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [5] The retrospective analysis of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
    Ueno, M.
    Kobayashi, S.
    Ohkawa, S.
    Tezuka, S.
    Moriya, S.
    Morimoto, M.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 67 - 67
  • [6] Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer
    Lim, Alexander
    Kim, Dae Won
    Kim, Kunhwa
    Kim, Richard D.
    Bottiglieri, Salvatore Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [7] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Borazanci, Erkut
    Schroeder, Katy
    Jameson, Gayle S.
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Han, Sung Yong
    Kim, Dong Uk
    Seol, Young Mi
    Kim, Suk
    Lee, Nam Kyung
    Hong, Seung Baek
    Seo, Hyung-Il
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (17) : 3718 - 3729
  • [9] Comparison of gemcitabine plus nab-paclitaxel and FOLFIRINOX in metastatic pancreatic cancer
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    [J]. World Journal of Clinical Cases, 2020, (17) : 3718 - 3729
  • [10] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
12345